A PHASE 3, RANDOMISED CONTROLLED TRIAL COMPARING UPADACITINIB MONOTHERAPY TO MTX MONOTHERAPY IN MTX-NAIVE PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS

被引：0
|
作者：
van Vollenhoven, R. [1 ]
Takeuchi, T. [2 ]
Pangan, A. L. [3 ]
Friedman, A. [3 ]
Mohamed, F. [3 ]
Chen, S. [3 ]
Rischmueller, M. [4 ,5 ]
Blanco, R. [6 ]
Xavier, R. M. [7 ]
Strand, V. [8 ]
机构：
[1] Amsterdam Rheumatol & Immunol Ctr ARC, Rhematol, Amsterdam, Netherlands
[2] Keio Univ, Sch Med, Rhematol, Tokyo, Japan
[3] AbbVie, Rhematol, N Chicago, IL USA
[4] Queen Elizabeth Hosp, Rhematol, Adelaide, SA, Australia
[5] Univ Adelaide, Adelaide, SA, Australia
[6] Hosp Univ Marques Valdecilla, Rhematol, Cantabria, Spain
[7] Univ Fed Rio Grande do Sul, Rhematol, Porto Alegre, RS, Brazil
[8] Stanford Univ, Rhematol, Palo Alto, CA 94304 USA
来源：
RHEUMATOLOGY | 2019年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
059
引用
收藏
页码：64 / 64
页数：1
相关论文
共 50 条
  • [1] A Phase 3, Randomized, Controlled Trial Comparing Upadacitinib Monotherapy to MTX Monotherapy in MTX-Naive Patients with Active Rheumatoid Arthritis
    van Vollenhoven, Ronald
    Takeuchi, Tsutomu
    Pangan, Aileen L.
    Friedman, Alan
    Mohamed, Mohamed-Eslam
    Chen, Su
    Rischmueller, Maureen
    Blanco, Ricardo
    Xavier, Ricardo M.
    Strand, Vibeke
    [J]. ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [2] A PHASE 3, RANDOMIZED, DOUBLE-BLIND STUDY COMPARING UPADACITINIB MONOTHERAPY TO MTX MONOTHERAPY IN MTX-NAIVE PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS
    van Vollenhoven, R.
    Takeuchi, T.
    Pangan, A. L.
    Friedman, A.
    Mohamed, M. F.
    Chen, S.
    Rischmueller, M.
    Blanco, R.
    Xavier, R. M.
    Strand, V.
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2019, 25 : S4 - S4
  • [3] MONOTHERAPY WITH UPADACITINIB IN MTX-NAIVE PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS AT 48 WEEKS
    van Vollenhoven, R.
    Takeuchi, T.
    Pangan, A. L.
    Friedman, A.
    Chen, S.
    Rischmueller, M.
    Blanco, R.
    Xavier, R. M.
    Strand, V.
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2020, 26 : 12 - 12
  • [4] Monotherapy with Upadacitinib in MTX-naive Patients with Rheumatoid Arthritis: Results at 48 Weeks
    van Vollenhoven, Ronald
    Takeuchi, Tsutomu
    Pangan, Aileen
    Friedman, Alan
    Chen, Su
    Rischmueller, Maureen
    Blanco, Ricardo
    Xavier, Ricardo Machado
    Strand, Vibeke
    [J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [5] Comparison of the Effects of Upadacitinib Monotherapy with MTX on Protein Biomarkers in MTX-Naive and MTX-Inadequate Responders in Patients with Active Rheumatoid Arthritis: Results from the SELECT-EARLY and SELECT-MONOTHERAPY Phase 3 Studies
    Sornasse, Thierry
    Camp, Heidi
    Cai, Fang
    Klaff, Justin
    McInnes, Iain
    [J]. ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 2563 - 2565
  • [6] MONOTHERAPY WITH UPADACITINIB IN MTX-NAIVE PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS AT 48 WEEKS FROM THE SELECT-EARLY STUDY
    van Vollenhoven, Ronald
    Takeuchi, Tsutomu
    Pangan, Aileen
    Friedman, Alan
    Chen, Su
    Rischmueller, Maureen
    Blanco, Ricardo
    Xavier, Ricardo
    Strand, Vibeke
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 376 - 377
  • [7] Relationship between clinical and patient-reported outcomes in a phase 3 trial of tofacitinib or MTX in MTX-naive patients with rheumatoid arthritis
    Fleischmann, Roy
    Strand, Vibeke
    Wilkinson, Bethanie
    Kwok, Kenneth
    Bananis, Eustratios
    [J]. RMD OPEN, 2016, 2 (01):
  • [8] TOCILIZUMAB (TCZ) AS COMBINATION THERAPY AND AS MONOTHERAPY VS METHOTREXATE (MTX) IN MTX-NAIVE PATIENTS WITH EARLY RHEUMATOID ARTHRITIS: PATIENT-REPORTED OUTCOMES (PROS) FROM A RANDOMIZED, PLACEBO-CONTROLLED TRIAL
    Burmester, G.
    Blanco, R.
    Keiserman, M.
    Rigby, W.
    van Vollenhoven, R. F.
    Dimonaco, S. M.
    Grzeschik, S. M.
    Mitchell, N.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 672 - 672
  • [9] THE GO-DACT PROTOCOL: A RANDOMISED CONTROLLED TRIAL TO COMPARE THE EFFICACY OF GOLIMUMAB IN COMBINATION WITH METHOTREXATE (MTX) VERSUS MTX MONOTHERAPY, IN IMPROVING DACTYLITIS AND ENTHESITIS, IN MTX NAIVE PSORIATIC ARTHRITIS PATIENTS
    Vieira-Sousa, Elsa
    Canhao, Helena
    Fonseca, Joao Eurico
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : A79 - A79
  • [10] Etanercept (ETN) with methotrexate (MTX) is better than ETN monotherapy in patients with active rheumatoid arthritis despite MTX therapy: a randomized trial
    Kameda, Hideto
    Ueki, Yukitaka
    Saito, Kazuyoshi
    Nagaoka, Shouhei
    Hidaka, Toshihiko
    Atsumi, Tatsuya
    Tsukano, Michishi
    Kasama, Tsuyoshi
    Shiozawa, Shunichi
    Tanaka, Yoshiya
    Takeuchi, Tsutomu
    [J]. MODERN RHEUMATOLOGY, 2010, 20 (06) : 531 - 538
12345